BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fellmer PT, Sato K, Tanaka R, Okamoto T, Kato Y, Kobayashi M, Shibuya M, Obara T. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas. Surgery. 1999;126:1056-1061; discussion 1061-1062. [PMID: 10598188 DOI: 10.1067/msy.2099.101432] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Kawakami M, Furuhata T, Kimura Y, Yamaguchi K, Hata F, Sasaki K, Hirata K. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer. Surgery. 2003;133:300-308. [PMID: 12660643 DOI: 10.1067/msy.2003.45] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
2 Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer. 2003;97:457-464. [PMID: 12518370 DOI: 10.1002/cncr.11073] [Cited by in Crossref: 115] [Cited by in F6Publishing: 99] [Article Influence: 6.4] [Reference Citation Analysis]
3 Ogawa E, Takenaka K, Yanagihara K, Kurozumi M, Manabe T, Wada H, Tanaka F. Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. Br J Cancer. 2004;91:498-503. [PMID: 15226767 DOI: 10.1038/sj.bjc.6601992] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
4 Swartz MA, Skobe M. Lymphatic function, lymphangiogenesis, and cancer metastasis. Microsc Res Tech 2001;55:92-9. [PMID: 11596154 DOI: 10.1002/jemt.1160] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 6.3] [Reference Citation Analysis]
5 Shin WS, Rockson SG. Animal models for the molecular and mechanistic study of lymphatic biology and disease. Ann N Y Acad Sci 2008;1131:50-74. [PMID: 18519959 DOI: 10.1196/annals.1413.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
6 Yu J, Zhang X, Kuzontkoski PM, Jiang S, Zhu W, Li DY, Groopman JE. Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway. Cell Commun Signal 2014;12:25. [PMID: 24708522 DOI: 10.1186/1478-811X-12-25] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 3.1] [Reference Citation Analysis]
7 Lai C, Chen K, Hung C, Kuo S, Chang Y, Lin M, Chang K, Wu M. Serum vascular endothelial growth factor-D levels correlate with cervical lymph node metastases in papillary thyroid carcinoma. Growth Factors 2011;29:57-62. [DOI: 10.3109/08977194.2011.557373] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
8 Clarijs R, Ruiter DJ, de Waal RMW. Lymphangiogenesis in malignant tumours: does it occur? J Pathol 2001;193:143-6. [DOI: 10.1002/path.808] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 3.5] [Reference Citation Analysis]
9 Ichikura T, Tomimatsu S, Ohkura E, Mochizuki H. Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma. J Surg Oncol. 2001;78:132-137. [PMID: 11579392 DOI: 10.1002/jso.1133] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 2.9] [Reference Citation Analysis]
10 Gosain R, Alexander JS, Gill A, Perez C. Radioactive Iodine-Refractory Differentiated Thyroid Cancer in the Elderly. Curr Oncol Rep 2018;20:82. [PMID: 30206719 DOI: 10.1007/s11912-018-0736-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Turner HE, Harris AL, Melmed S, Wass JA. Angiogenesis in endocrine tumors. Endocr Rev 2003;24:600-32. [PMID: 14570746 DOI: 10.1210/er.2002-0008] [Cited by in Crossref: 176] [Cited by in F6Publishing: 152] [Article Influence: 10.4] [Reference Citation Analysis]
12 Šelemetjev S, Ðoric I, Paunovic I, Tatic S, Cvejic D. Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma. Am J Clin Pathol 2016;146:594-602. [PMID: 27806941 DOI: 10.1093/ajcp/aqw184] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
13 Puxeddu E, Fagin JA. Genetic markers in thyroid neoplasia. Endocrinol Metab Clin North Am 2001;30:493-513, x. [PMID: 11444172 DOI: 10.1016/s0889-8529(05)70196-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
14 Bolat F, Gumurdulu D, Erkanli S, Kayaselcuk F, Zeren H, Ali Vardar M, Kuscu E. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma. Pathol Res Pract. 2008;204:379-387. [PMID: 18343598 DOI: 10.1016/j.prp.2008.01.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
15 Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001;7:192-198. [PMID: 11175850 DOI: 10.1038/84643] [Cited by in Crossref: 1193] [Cited by in F6Publishing: 1017] [Article Influence: 59.7] [Reference Citation Analysis]
16 Xu LL, Li ZJ, Niu XL, Deng WM. The mechanisms of IL-17A on promoting tumor metastasis. Int Rev Immunol 2017;36:360-9. [PMID: 28933960 DOI: 10.1080/08830185.2017.1356296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Proietti A, Sartori C, Borrelli N, Giannini R, Materazzi G, Leocata P, Elisei R, Vitti P, Miccoli P, Basolo F. Follicular-derived neoplasms: morphometric and genetic differences. J Endocrinol Invest 2013;36:1055-61. [PMID: 23888303 DOI: 10.3275/9063] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
18 Cassella M, Skobe M. Lymphatic vessel activation in cancer. Ann N Y Acad Sci. 2002;979:120-130. [PMID: 12543722 DOI: 10.1111/j.1749-6632.2002.tb04873.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
19 Seyed Jafari SM, Wiedmer C, Cazzaniga S, Frangež Ž, Shafighi M, Beltraminelli H, Weber B, Simon HU, Hunger RE. Correlation of Vascular Endothelial Growth Factor subtypes and their receptors with melanoma progression: A next-generation Tissue Microarray (ngTMA) automated analysis. PLoS One 2018;13:e0207019. [PMID: 30408085 DOI: 10.1371/journal.pone.0207019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
20 George ML, Tutton MG, Janssen F, Arnaout A, Abulafi AM, Eccles SA, Swift RI. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 2001;3:420-7. [PMID: 11687953 DOI: 10.1038/sj.neo.7900186] [Cited by in Crossref: 136] [Cited by in F6Publishing: 115] [Article Influence: 7.2] [Reference Citation Analysis]
21 Klubo-Gwiezdzinska J, Junik R, Kopczynska E, Juraniec O, Kardymowicz H. The comparison of serum vascular endothelial growth factor levels between patients with metastatic and non-metastatic thyroid cancer, and patients with nontoxic multinodular goiter. Eur J Endocrinol 2007;157:521-7. [PMID: 17893268 DOI: 10.1530/EJE-07-0252] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
22 Gong L, Chen P, Liu X, Han Y, Zhou Y, Zhang W, Li H, Li C, Xie J. Expressions of D2-40, CK19, galectin-3, VEGF and EGFR in papillary thyroid carcinoma. Gland Surg 2012;1:25-32. [PMID: 25083424 DOI: 10.3978/j.issn.2227-684X.2012.03.02] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
23 Ghoshal A, Garmo H, Arthur R, Carroll P, Holmberg L, Hammar N, Jungner I, Malmström H, Lambe M, Walldius G, Van Hemelrijck M. Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum. Oncotarget 2018;9:774-82. [PMID: 29416653 DOI: 10.18632/oncotarget.22891] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Erdem H, Gündogdu C, Sipal S. Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma. Exp Mol Pathol 2011;90:312-7. [PMID: 21335003 DOI: 10.1016/j.yexmp.2011.01.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
25 Lennard CM, Patel A, Wilson J, Reinhardt B, Tuman C, Fenton C, Blair E, Francis GL, Tuttle R. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer. Surgery 2001;129:552-8. [DOI: 10.1067/msy.2001.112592] [Cited by in Crossref: 101] [Cited by in F6Publishing: 76] [Article Influence: 5.1] [Reference Citation Analysis]
26 Sun Z, Wang Z, Zhang M. Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy: VEGF-C and ESCC. Asia-Pacific Journal of Clinical Oncology 2012;8:e68-76. [DOI: 10.1111/j.1743-7563.2011.01514.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
27 Lin J. Papillary thyroid carcinoma with lymph node metastases. Growth Factors 2009;25:41-9. [DOI: 10.1080/08977190601000095] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
28 Lei Y, Li B, Tong S, Qi L, Hu X, Cui Y, Li Z, He W, Zu X, Wang Z, Chen M. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells. PLoS One 2015;10:e0117809. [PMID: 25658842 DOI: 10.1371/journal.pone.0117809] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
29 Giorgadze TA, Baloch ZW, Pasha T, Zhang PJ, Livolsi VA. Lymphatic and blood vessel density in the follicular patterned lesions of thyroid. Mod Pathol 2005;18:1424-31. [PMID: 15920537 DOI: 10.1038/modpathol.3800452] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
30 Siironen P, Louhimo J, Nordling S, Ristimäki A, Mäenpää H, Haapiainen R, Haglund C. Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients. Tumour Biol 2005;26:57-64. [PMID: 15870511 DOI: 10.1159/000085586] [Cited by in Crossref: 64] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
31 Morita H, Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Nishimura C, Igarashi Y, Miki K, Ishii T. Histopathological predictor for regional lymph node metastasis in gastric cancer. Virchows Arch. 2009;454:143-151. [PMID: 19104832 DOI: 10.1007/s00428-008-0717-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
32 Abe N, Ohtake T, Saito K, Kumamoto K, Sugino T, Takenoshita S. Clinicopathological significance of lymphangiogenesis detected by immunohistochemistry using D2-40 monoclonal antibody in breast cancer. Fukushima J Med Sci 2016;62:57-63. [PMID: 27210308 DOI: 10.5387/fms.2015-10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
33 Liu P, Chen W, Zhu H, Liu B, Song S, Shen W, Wang F, Tucker S, Zhong B, Wang D. Expression of VEGF-C Correlates with a Poor Prognosis Based on Analysis of Prognostic Factors in 73 Patients with Esophageal Squamous Cell Carcinomas. Japanese Journal of Clinical Oncology 2009;39:644-50. [DOI: 10.1093/jjco/hyp079] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
34 Shin WS, Rockson SG. Lymphangiogenesis: Recapitulation of Angiogensis in Health and Disease. In: Forough R, editor. New Frontiers in Angiogenesis. Dordrecht: Springer Netherlands; 2006. pp. 159-202. [DOI: 10.1007/1-4020-4327-9_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
35 Liang H, Zhong Y, Luo Z, Huang Y, Lin H, Luo M, Zhan S, Xie K, Ma Y, Li QQ. Assessment of Biomarkers for Clinical Diagnosis of Papillary Thyroid Carcinoma with Distant Metastasis. Int J Biol Markers 2010;25:38-45. [DOI: 10.1177/172460081002500106] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 7.7] [Reference Citation Analysis]
36 Klein M, Catargi B. VEGF in physiological process and thyroid disease. Ann Endocrinol (Paris) 2007;68:438-48. [PMID: 17991452 DOI: 10.1016/j.ando.2007.09.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
37 Kung S, Lee C, Yang A, Chi C, Tseng L, Wu C. Expression of c-Kit, Flk-1, and Flk-2 Receptors in Benign and Malignant Tumors of Follicular Epithelial Origin. Journal of the Chinese Medical Association 2006;69:74-9. [DOI: 10.1016/s1726-4901(09)70117-0] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
38 de Araujo-filho VJF, Alves VAF, de Castro IV, Lourenço SV, Cernea CR, Brandão LG, Ferraz AR. Vascular Endothelial Growth Factor Expression in Invasive Papillary Thyroid Carcinoma. Thyroid 2009;19:1233-7. [DOI: 10.1089/thy.2008.0179] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
39 Gild ML, Topliss DJ, Learoyd D, Parnis F, Tie J, Hughes B, Walsh JP, McLeod DSA, Clifton-Bligh RJ, Robinson BG. Clinical guidance for radioiodine refractory differentiated thyroid cancer. Clin Endocrinol (Oxf) 2018;88:529-37. [PMID: 29095527 DOI: 10.1111/cen.13508] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
40 Tang RF, Itakura J, Aikawa T, Matsuda K, Fujii H, Korc M, Matsumoto Y. Overexpression of Lymphangiogenic Growth Factor VEGF-C in Human Pancreatic Cancer: . Pancreas 2001;22:285-92. [DOI: 10.1097/00006676-200104000-00010] [Cited by in Crossref: 55] [Cited by in F6Publishing: 81] [Article Influence: 2.8] [Reference Citation Analysis]
41 Eloy C, Santos J, Soares P, Sobrinho-simões M. Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma. Virchows Arch 2011;459:595-605. [DOI: 10.1007/s00428-011-1161-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
42 Taniguchi K, Iida T, Hori T, Yagi S, Imai H, Shiraishi T, Uemoto S. Impact of lymph node micrometastasis in hilar bile duct carcinoma patients. World J Gastroenterol. 2006;12:2549-2555. [PMID: 16688800 DOI: 10.3748/wjg.v12.i16.2549] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
43 Tuttle RM, Fleisher M, Francis GL, Robbins RJ. Serum Vascular Endothelial Growth Factor Levels Are Elevated in Metastatic Differentiated Thyroid Cancer but Not Increased by Short-Term TSH Stimulation. The Journal of Clinical Endocrinology & Metabolism 2002;87:1737-42. [DOI: 10.1210/jcem.87.4.8388] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
44 Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, Detmar M. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol. 2001;159:893-903. [PMID: 11549582 DOI: 10.1016/s0002-9440(10)61765-8] [Cited by in Crossref: 278] [Cited by in F6Publishing: 126] [Article Influence: 13.9] [Reference Citation Analysis]
45 Reis-Filho JS, Schmitt FC. Lymphangiogenesis in tumors: what do we know. Microsc Res Tech. 2003;60:171-180. [PMID: 12539171 DOI: 10.1002/jemt.10255] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
46 Itoh A, Iwase K, Jimbo S, Yamamoto H, Yamamoto N, Kokubo M, Senda T, Nakai A, Nagagasaka A, Nagasaka T, Hibi Y, Seko T. Expression of Vascular Endothelial Growth Factor and Presence of Angiovascular Cells in Tissues from Different Thyroid Disorders. World J Surg 2010;34:242-8. [DOI: 10.1007/s00268-009-0344-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]